Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells-Reference-Cited by-同舟云学术

Co‑expression of SLC20A1 and ALDH1A3 is associated with poor prognosis, and SLC20A1 is required for the survival of ALDH1‑positive pancreatic cancer stem cells

Published:2024-07-05 Issue:3 Volume:28 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Matsuoka Izumi¹,Kasai Takahiro¹,Onaga Chotaro¹,Ozaki Ayaka¹,Motomura Hitomi¹,Maemura Yuki¹,Tada Yuna¹,Mori Haruka¹,Hara Yasushi²,Xiong Yuyun¹,Sato Keiko³,Tamori Shoma¹,Sasaki Kazunori⁴,Ohno Shigeo⁴,Akimoto Kazunori¹

Affiliation:

1. Department of Medicinal and Life Sciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Chiba 278‑8510, Japan

2. Research Institute for Biomedical Sciences, Tokyo University of Science, Noda, Chiba 278‑8510, Japan

3. Research Division of Medical Data Science, Research Institute for Science and Technology, Tokyo University of Science, Noda, Chiba 278‑8510, Japan

4. Laboratory of Cancer Biology, Institute for Diseases of Old Age, Juntendo University School of Medicine, Tokyo 113‑8421, Japan

Publisher

Spandidos Publications

Reference51 articles.

1. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Cancer statistics, 2023;Siegel;CA Cancer J Clin,2023

3. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes;McGuigan;World J Gastroenterol,2018

4. Molecular pathogenesis of pancreatic cancer;Grant;Prog Mol Biol Transl Sci,2016

5. An introduction to pancreatic adenocarcinoma genetics, pathology and therapy;Kern;Cancer Biol Ther,2002